Artiva Biotherapeutics (ARTV) Stock Chart & Stock Price History $2.92 +0.03 (+0.86%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Artiva Biotherapeutics Stock Price Performance The Artiva Biotherapeutics (ARTV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.26%, with a year-to-date return of -70.98%. In the past month, the stock has increased 5.22%, reflecting recent market activity. As of the latest close, Artiva Biotherapeutics traded at $3.00 with a market cap of $73.29 million and volume of 25,200 shares. Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.85%1 Month Performance+5.22%3 Month Performance+68.10%Year-To-Date Performance-70.98%1 Year Performance-80.26% ARTV Stock Chart for Thursday, October, 9, 2025 ARTV Chart by TradingView Artiva Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$2.90$3.00+3.45%$3.03$2.8925,200 shs$73.29 million10/07/2025$2.93$2.90-1.02%$2.97$2.8233,124 shs$70.84 million10/06/2025$2.95$2.93-0.68%$3.00$2.9228,475 shs$71.58 million10/03/2025$2.95$2.95$3.00$2.8644,873 shs$72.07 million10/02/2025$2.92$2.95+1.03%$2.99$2.8719,120 shs$72.07 million10/01/2025$2.87$2.92+1.74%$2.99$2.8438,819 shs$71.32 million09/30/2025$2.92$2.87-1.71%$2.99$2.8060,863 shs$70.11 million09/29/2025$2.96$2.92-1.35%$2.98$2.8670,545 shs$71.34 million09/26/2025$3.01$2.96-1.66%$3.01$2.82193,839 shs$72.31 million09/25/2025$2.88$3.01+4.51%$3.08$2.85150,313 shs$73.52 million Get the Latest News and Ratings for ARTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$2.59$2.88+11.20%$2.89$2.52156,915 shs$70.36 million09/23/2025$2.70$2.59-4.07%$2.86$2.5817,155 shs$63.27 million09/22/2025$2.88$2.70-6.25%$3.00$2.5595,282 shs$65.95 million09/19/2025$2.38$2.88+21.01%$2.98$2.37478,681 shs$70.35 million09/18/2025$2.28$2.38+4.39%$2.43$2.29119,969 shs$58.14 million09/17/2025$2.37$2.28-3.80%$2.55$2.22107,790 shs$55.70 million09/16/2025$2.35$2.37+0.85%$2.50$2.3050,135 shs$57.89 million09/15/2025$2.55$2.35-7.84%$2.62$2.32100,475 shs$57.41 million09/12/2025$2.66$2.55-4.14%$2.75$2.5552,866 shs$62.30 million09/11/2025$2.70$2.66-1.48%$2.75$2.56188,829 shs$64.98 million09/10/2025$2.78$2.70-2.88%$2.85$2.6548,094 shs$65.95 million09/09/2025$3.09$2.78-10.03%$3.20$2.7394,042 shs$67.92 million09/08/2025$3.61$3.09-14.40%$3.70$3.00119,439 shs$75.49 million Related Companies AARD Stock Price Chart ACIU Stock Price Chart TECX Stock Price Chart IMAB Stock Price Chart NMRA Stock Price Chart SOPH Stock Price Chart ABEO Stock Price Chart ALLO Stock Price Chart JBIO Stock Price Chart FHTX Stock Price Chart Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARTV) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
